2022
DOI: 10.2147/clep.s353389
|View full text |Cite
|
Sign up to set email alerts
|

Association Between Serum Total Bilirubin and COPD: Results from a Cross-Sectional Study and a Bidirectional Mendelian Randomization Analysis

Abstract: Background The potential protective role of serum total bilirubin (TB) for chronic obstructive pulmonary disease (COPD) is controversial. We aimed to investigate whether serum TB could prevent airflow limitation (reduce the risk of COPD) and whether these associations were causal or reversely causal. Methods We conducted a multi-center and cross-sectional study including 3069 participants. Logistic regression model (LRM) with restricted cubic spline (RCS) and priori def… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…The inverse relationship of TBIL with COPD risk was fairly consistent with several prospective studies ( 8 , 34 ). However, a bidirectional Mendelian randomization analysis showed no causal relation between TBIL and COPD ( 35 ). Although higher TBIL levels within the normal range have been demonstrated to decrease the risk of cardiovascular disease through antioxidant and anti-inflammatory effects ( 36 ), the underlying mechanism for the protective effects of TBIL in COPD progression is unclear.…”
Section: Discussionmentioning
confidence: 99%
“…The inverse relationship of TBIL with COPD risk was fairly consistent with several prospective studies ( 8 , 34 ). However, a bidirectional Mendelian randomization analysis showed no causal relation between TBIL and COPD ( 35 ). Although higher TBIL levels within the normal range have been demonstrated to decrease the risk of cardiovascular disease through antioxidant and anti-inflammatory effects ( 36 ), the underlying mechanism for the protective effects of TBIL in COPD progression is unclear.…”
Section: Discussionmentioning
confidence: 99%